Contemporary Grading of Prostate Cancer: The Impact of Grading Criteria and the Significance of the Amount of Intraductal Carcinoma.
Gleason Score
cribriform pattern
intraductal carcinoma
prognostic grade group
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
29 Oct 2021
29 Oct 2021
Historique:
received:
10
10
2021
revised:
24
10
2021
accepted:
28
10
2021
entrez:
13
11
2021
pubmed:
14
11
2021
medline:
14
11
2021
Statut:
epublish
Résumé
(1) Background: Prognostic grade group (PGG) is an important prognostic parameter in prostate cancer that guides therapeutic decisions. The cribriform pattern and intraductal carcinoma (IDC) are two histological patterns, that have additional prognostic significance. However, discrepancies exist regarding the handling of IDC according to the guidelines published by two international genitourinary pathology societies. Furthermore, whether, in addition to its presence, the amount of IDC is also of importance has not been studied before. Lastly, the handling of tertiary patterns has also been a matter of debate in the literature. (2) Methods: A total of 129 prostatectomy cases were retrieved and a detailed histopathologic analysis was performed. (3) Results: Two cases (1.6%) upgraded their PGG, when IDC was incorporated in the grading system. The presence and the amount of IDC, as well as the presence of cribriform carcinoma were associated with adverse pathologic characteristics. Interestingly, in six cases (4.7%) there was a difference in PGG when using the different guidelines regarding the handling of tertiary patterns. In total, 6.2% of the cases would be assigned a different grade depending on the guidelines followed. (4) Conclusions: These findings highlight a potential area of confusion among pathologists and clinicians and underscore the need for a consensus grading system.
Identifiants
pubmed: 34771617
pii: cancers13215454
doi: 10.3390/cancers13215454
pmc: PMC8582560
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : University of Patras
ID : 56570000
Références
Am J Surg Pathol. 1998 Jul;22(7):840-8
pubmed: 9669346
Histopathology. 2019 Jan;74(1):146-160
pubmed: 30565302
Eur Urol. 2016 Apr;69(4):557-560
pubmed: 26563871
Am J Surg Pathol. 2021 Nov 1;45(11):1527-1533
pubmed: 34265803
Am J Surg Pathol. 2005 Sep;29(9):1228-42
pubmed: 16096414
Adv Anat Pathol. 2021 Jul 1;28(4):276-287
pubmed: 33990497
Hum Pathol. 2001 May;32(5):494-9
pubmed: 11381367
Eur Urol Oncol. 2018 May;1(1):21-28
pubmed: 31100224
Am J Surg Pathol. 2020 May;44(5):673-680
pubmed: 31876580
Int J Biol Markers. 2018 Nov;33(4):331-334
pubmed: 29945478
Histopathology. 2020 Nov;77(5):742-748
pubmed: 32542746
Prostate. 2015 Sep;75(12):1247-54
pubmed: 25917338
Pathol Res Pract. 2018 Oct;214(10):1681-1685
pubmed: 30195638
Eur Urol. 2015 Feb;67(2):342-6
pubmed: 24968968
Am J Surg Pathol. 2015 Oct;39(10):1383-9
pubmed: 26076065
Histopathology. 2020 Sep;77(3):503-507
pubmed: 32358793
J Urol. 2019 Oct;202(4):710-716
pubmed: 31059665
Curr Urol Rep. 2016 Mar;17(3):25
pubmed: 26874537
Am J Surg Pathol. 2020 Aug;44(8):e87-e99
pubmed: 32459716
Mo Med. 2018 Mar-Apr;115(2):151-155
pubmed: 30228708
BMC Cancer. 2018 Jan 2;18(1):8
pubmed: 29295717
Virchows Arch. 2019 May;474(5):525-534
pubmed: 30825003
Mod Pathol. 2006 Dec;19(12):1528-35
pubmed: 16980940
Arch Pathol Lab Med. 2012 Apr;136(4):418-25
pubmed: 22458904
Am J Clin Pathol. 2011 Jul;136(1):98-107
pubmed: 21685037
Eur Urol. 2010 Jun;57(6):1030-8
pubmed: 19853370
Prostate. 2014 May;74(6):680-7
pubmed: 24481730
J Pathol. 2019 Sep;249(1):79-89
pubmed: 30993692
Urol Oncol. 2013 Jan;31(1):93-8
pubmed: 21316989
Am J Surg Pathol. 2000 Apr;24(4):563-9
pubmed: 10757404
Urol Oncol. 2018 Apr;36(4):158.e1-158.e6
pubmed: 29288003
Transl Androl Urol. 2018 Feb;7(1):145-154
pubmed: 29594028
Eur J Cancer. 2021 Apr;147:74-83
pubmed: 33626496
Adv Anat Pathol. 2021 Jan;28(1):1-7
pubmed: 33027069
J Clin Oncol. 2020 Aug 20;38(24):2798-2811
pubmed: 32516092
Am J Surg Pathol. 2016 Feb;40(2):244-52
pubmed: 26492179
Int J Surg Pathol. 2020 Dec;28(8):918-924
pubmed: 32456482
J Urol. 1974 Jan;111(1):58-64
pubmed: 4813554
Arch Pathol Lab Med. 2021 Apr 1;145(4):461-493
pubmed: 32589068
Am J Clin Pathol. 2010 Apr;133(4):654-61
pubmed: 20231619
Eur Urol. 2020 Feb;77(2):191-198
pubmed: 31439369
Int J Urol. 2021 Jun;28(6):614-621
pubmed: 33580599
Eur Urol. 2016 Mar;69(3):428-35
pubmed: 26166626
Eur J Cancer. 2012 Jun;48(9):1318-25
pubmed: 22405699
Eur Urol. 2015 Mar;67(3):496-503
pubmed: 25154392
Prostate. 2019 Jul;79(10):1065-1070
pubmed: 31025722
Mod Pathol. 2011 Jan;24(1):16-25
pubmed: 20818340